SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-049742
Filing Date
2005-10-03
Accepted
2005-10-03 11:14:09
Documents
1
Period of Report
2005-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3681
  Complete submission text file 0001209191-05-049742.txt   5717
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CAMBRIDGE BIOTECH CORP 365 PLANTATION ST WORCESTER MA 01605
Business Address 365 PLANTATION ST C/O CAMBRIDGE BIOTECH CORP WORCESTER MA 01605 5087913511
RIGBY ALISON TAUNTON (Reporting) CIK: 0001024054 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 051116105